- Home
- APLT vs ASTL Comparison
APLT vs ASTL Comparison
Compare APLT & ASTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- ASTL
- Stock Information
- Founded
- APLT 2016
- ASTL 1902
- Country
- APLT United States
- ASTL Canada
- Employees
- APLT N/A
- ASTL N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- ASTL Steel/Iron Ore
- Sector
- APLT Health Care
- ASTL Industrials
- Exchange
- APLT Nasdaq
- ASTL Nasdaq
- Market Cap
- APLT 128.0M
- ASTL 1.0B
- IPO Year
- APLT 2019
- ASTL N/A
- Fundamental
- Price
- APLT $0.90
- ASTL $9.70
- Analyst Decision
- APLT Buy
- ASTL
- Analyst Count
- APLT 7
- ASTL 0
- Target Price
- APLT $6.10
- ASTL N/A
- AVG Volume (30 Days)
- APLT 8.4M
- ASTL 440.0K
- Earning Date
- APLT 11-07-2024
- ASTL 02-04-2025
- Dividend Yield
- APLT N/A
- ASTL 2.07%
- EPS Growth
- APLT N/A
- ASTL N/A
- EPS
- APLT N/A
- ASTL N/A
- Revenue
- APLT N/A
- ASTL $1,840,778,711.00
- Revenue This Year
- APLT N/A
- ASTL N/A
- Revenue Next Year
- APLT $2,664.24
- ASTL $15.21
- P/E Ratio
- APLT N/A
- ASTL N/A
- Revenue Growth
- APLT N/A
- ASTL N/A
- 52 Week Low
- APLT $0.77
- ASTL $6.67
- 52 Week High
- APLT $10.62
- ASTL $12.14
- Technical
- Relative Strength Index (RSI)
- APLT 19.46
- ASTL 42.01
- Support Level
- APLT $0.78
- ASTL $9.60
- Resistance Level
- APLT $0.90
- ASTL $9.86
- Average True Range (ATR)
- APLT 0.12
- ASTL 0.27
- MACD
- APLT 0.26
- ASTL 0.02
- Stochastic Oscillator
- APLT 20.97
- ASTL 49.48
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About ASTL Algoma Steel Group Inc.
Algoma Steel Group Inc is a Canadian company engaged in the production of clean and consistent light gauge steel. The company offers a range of hot and cold rolled steel sheet and plate products. The firm operates in a single segment of basic steel production including sheets, plates, slabs, and freights. The company's revenue is generated from contracts to produce, ship, and deliver steel products Geographically it serves Canada, the United States, and the rest of the world, whilst driving key revenue from domestic sales. The company generates the majority of its revenue from the sale of Steel sheets and strips.